Antineoplastic agent. Proteasome Inhibitor.
Packaging: 1 vial containing 3.5 mg
Lyophilized powder for injection solution.
VBRP
Dabifib 150®
Dabigatran Etexilate
Anticoagulant
Hard Capsules
Bottle of 30 capsules
Oral Use
VBRP
Dabifib 110®
Dabigatran Etexilate
Anticoagulant
Hard Capsules
Bottle of 30 capsules
Oral Use
VBRP
Dabifib 75®
Dabigatran Etexilate
Anticoagulant
Hard Capsules
Bottle of 30 capsules
Oral Use
VBRP
Xpaero®
Axitinib
Antineoplasics
Coated tablets
1 bottle containing 60 tablets
Oral use
VBRP
Voxzogo® 1.2 mg
Vosoritida
Agent for bone growth disorders
Lyophilized powder for injectable solution
Box containing 10 vials of lyophilized powder + 10 pre-filled syringes with solvent + 10 needles + 10 syringes
Subcutaneous use
VBRP
Voxzogo® 0.56 mg
Vosoritida
Agent for bone growth disorders
Lyophilized powder for injectable solution
Box containing 10 vials of lyophilized powder + 10 pre-filled syringes with solvent + 10 needles + 10 syringes
Subcutaneous use
VBRP
Voxzogo® 0.4 mg
Vosoritida
Agent for bone growth disorders
Lyophilized powder for injectable solution
Box containing 10 vials of lyophilized powder + 10 pre-filled syringes with solvent + 10 needles + 10 syringes
Subcutaneous use
VBRP
Eletraz®
Trace elements
Minerals (trace elements). To supplement parenteral nutrition.
Intravenous Infusion
1 bottle with 100 mL
Intravenous use
VBRP
Groverine®200 mg
Etravirine
Antiretrovirals
Tablets
Bottle with 60 tablets
Oral use
VBRP